A menopause care brand has run its prescription program for a year, and patients keep asking the same two things: what can I take for sleep, and what should I put on my skin? The founder finds a supplement maker with two offers. It can ship a stock sleep formula next month with her brand's label, or develop a custom formula only her brand will sell. That is the private label vs. white label decision, and for a health brand it involves more than branding and margins.
The care side of her business already runs on a white-label telehealth platform. The intake, prescribers, and pharmacy all operate under her brand name. The new products raise a different question: once her name is on the bottle, what is her company responsible for?
Private Label vs White Label at a Glance
A white-label product is a standard product that a manufacturer makes once and sells to many brands, each of which puts its own label on it. A private-label product is made to one brand's formula or specifications and sold only by that brand. Both end up with the brand's name on the package. The difference is who decides what goes inside and who else can sell it.
| Factor | White label | Private label |
|---|
| Formula or specification | The manufacturer's standard formula | Your formula or specification |
| Exclusivity | Other brands can sell the same product | Only your brand sells it |
| Time to launch | Shorter, because the product already exists | Longer, because of development, testing, and first production |
| Upfront cost and order size | Usually lower | Usually higher |
| Where differentiation comes from | Branding, price, and service | The product itself |
| Who answers to the FDA as the name on the label | Your brand | Your brand |
The last row is the one most comparisons leave out, and it matters far more for supplements and skincare than for tote bags or phone cases.
"White Label" Means Two Different Things in Telehealth
Telehealth founders hear "white label" in two senses. The first is a white-label care platform: the intake questionnaire, prescribing workflow, pharmacy connection, and patient portal, all running under the brand's name. The second is white-label products: stock formulas a brand sells on its own retail shelf.
Prescription medication does not fit the retail model behind either term. A licensed pharmacy dispenses each prescription under its own license, and federal law requires the label to name the pharmacy and the prescriber. Compounded medications follow the same logic. A 503A compounding pharmacy prepares a medication for an individual patient based on a prescription, so there is no retail product to put a private label on, even though the brand can still shape the packaging.
That puts the private label decision where it belongs: on the non-prescription shelf, with supplements, skincare, and other products patients buy without a prescription.
Your Name on the Label Brings the Same FDA Duties Either Way
Here is the part that changes the comparison. For supplements and cosmetics, FDA's rules attach to the company whose name appears on the label. A white-label product carries your name just like a private-label product, so choosing a stock formula doesn't reduce your obligations.
Supplements
FDA calls the manufacturer, packer, or distributor whose name appears on a dietary supplement label the responsible person. According to FDA guidance on adverse event reporting for dietary supplements, that company must submit every serious adverse event report it receives to FDA no later than 15 business days after receiving it, and it must keep the related records for six years.
Manufacturing quality is not fully handed off either. FDA's small entity compliance guide for dietary supplement manufacturing explains that a distributor that has a manufacturer make product under its own label has an obligation to know what manufacturing activities are performed and how. That distributor also needs to decide whether to approve and release the product for distribution.
Skincare and Cosmetics
The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) works the same way. FDA's MoCRA overview defines the responsible person as the manufacturer, packer, or distributor of a cosmetic product whose name appears on the label. That company must report serious adverse events to the FDA within 15 business days, keep records supporting the product's safety substantiation, and list each marketed cosmetic product and its ingredients with the FDA, with annual updates.
What to Put in the Supplier Contract
Because these duties stay with the brand, the supplier agreement should make them workable. It should say how quickly the supplier forwards any adverse event reports it receives about your product, which specifications and test results it shares for each batch, and who does what if a product has to be recalled. Standard supplier terms may not align with your reporting deadlines, so review them with those deadlines in mind and have a lawyer who works with FDA-regulated products review the agreement before the first order.
When White Label Is the Better Start
White label fits when speed and learning matter more than owning the formula. A brand adding a supplement next to an existing program often does not know yet which products patients will reorder. A stock formula lets you test demand without paying for development, and it keeps the first order smaller while the brand still works out its startup budget.
It also suits categories where a standard version is good enough, such as a basic electrolyte mix or a gentle cleanser. Ask the supplier for the formula documentation before you sign, because your company will be the one answering questions about it.
When Private Label Is Worth the Extra Time
Private label earns its cost when the product is part of what makes the brand different. A serum built around the brand's clinical focus, or a supplement formulated for the patient population it already treats, is hard to copy when no competitor can buy the same formula from the same supplier.
The trade-offs are real. Development and testing take longer, first orders are usually larger, and the brand must provide evidence for whatever it claims about its formula. You also design the packaging from scratch, from the label layout to the product images on the storefront.
A Practical Split for a Telehealth Brand
Most health brands do not need one model for everything. For a direct-to-consumer care brand, one sequence that keeps risk low looks like this:
- Run prescription care on a white-label platform, with licensed clinicians and pharmacies doing the licensed work.
- Launch retail add-ons as white-label products to learn what patients actually buy and reorder.
- Move proven products to a private-label formula once demand justifies the development time.
Where Bask Fits
Bask Health runs the white-label side of that split. Brands use the Bask builder to create their website, intake questionnaire, and patient portal under their own domain. Every plan includes integrated doctor groups, and prescriptions route through Bask's pharmacy fulfillment network to patients in all 50 states. For compounding, partner pharmacies prepare formulations to the prescriber's specifications, and the brand can customize medication packaging.
The platform supports OTC products and medical devices as well as prescription treatments, with synchronous or asynchronous care, so prescription programs and non-prescription products can sit in the same storefront and checkout. Bask is HIPAA-compliant and LegitScript-approved, with SOC 2 Type II controls. More than 250 U.S. telehealth companies run on it, and brands launch in days rather than months.
FAQs
Is It Legal to Private Label Supplements or Skincare?
Yes. Private labeling is a common and legal arrangement for supplements and cosmetics. The label must still meet FDA labeling rules, and the company named on it assumes responsible-person duties, including reporting serious adverse events to the FDA within 15 business days.
Who Is Responsible if a White-Label Supplement Causes a Serious Adverse Event?
The company whose name appears on the label. For a white-label supplement sold under your brand, that is usually your company, even though another company made the product. Your supplier agreement should make sure reports reach you quickly.
Can a Telehealth Brand Private Label Prescription Medication?
Not in the retail sense. A licensed pharmacy dispenses prescription medication for each patient, and the prescription label names the pharmacy and the prescriber. A brand can shape the packaging and patient experience around the medication, but the pharmacy still handles dispensing.
Is White Label Cheaper Than Private Label?
Usually, at the start. White-label products skip formula development and often allow smaller first orders. Private label costs more up front, but it gives the brand a product competitors cannot buy from the same supplier, which can support stronger pricing later.
Can a Brand Switch From White Label to Private Label Later?
Yes. Starting with white label and moving a proven product to private label is a reasonable path. Track reorder rates and patient feedback on the white-label version, and expect a new development and testing cycle before the private-label version ships.
Pick the Model Per Product, Not Per Brand
Back to the menopause brand. Her prescription care stays on a white-label platform, because that is where licensed partners do the licensed work. The sleep supplement can start as white label while she learns whether patients reorder it. The skin serum that patients connect with her brand may be the one worth a private-label formula. Whichever route each product takes, her company's name on the label carries the reporting and recordkeeping duties, so the supplier contracts and records need to be ready before the first box ships.
References
- U.S. Food and Drug Administration. (2013). Questions and answers regarding adverse event reporting and recordkeeping for dietary supplements as required by the Dietary Supplement and Nonprescription Drug Consumer Protection Act. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/guidance-industry-questions-and-answers-regarding-adverse-event-reporting-and-recordkeeping-dietary
- U.S. Food and Drug Administration. (2010). Small entity compliance guide: Current good manufacturing practice in manufacturing, packaging, labeling, or holding operations for dietary supplements. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/small-entity-compliance-guide-current-good-manufacturing-practice-manufacturing-packaging-labeling
- U.S. Food and Drug Administration. (n.d.). Modernization of Cosmetics Regulation Act of 2022 (MoCRA). https://www.fda.gov/cosmetics/cosmetics-laws-regulations/modernization-cosmetics-regulation-act-2022
